Lucira Health to Announce Fourth Quarter 2021 Financial Results
February 28 2022 - 5:00PM
Lucira Health, Inc. (“Lucira Health” or “Lucira”) (Nasdaq: LHDX), a
medical technology company focused on the development and
commercialization of transformative and innovative infectious
disease test kits, today announced that the company will report
fourth quarter 2021 financial results on, Thursday, March 10, 2022.
Lucira’s management will host a conference call and webcast at 1:30
p.m. PT / 4:30 p.m. ET that day to discuss the financial results
and provide a corporate update.
Conference Call and Webcast DetailsThe
conference call can be accessed by dialing (833) 562-0151 for
participants in the U.S. or Canada and (661) 567-1232 for
international callers, using conference ID 9897752. A live and
archived webcast of the event can be accessed through the following
link ir.lucirahealth.com.
About Lucira Health, Inc.
Lucira is a medical technology company focused on the
development and commercialization of transformative and innovative
infectious disease test kits. Lucira's testing platform produces
lab quality molecular testing in a single-use, consumer-friendly,
palm-size test kit powered by two AA batteries. Lucira designed its
test kits to provide accurate, reliable, and on-the-spot molecular
test results anywhere and at any time. The Lucira™ Check-It
COVID-19 Test Kit (OTC) and Lucira™ COVID-19 All-In-One Test Kit
(Rx) are designed to provide a clinically relevant COVID-19 result
within 30 minutes from sample collection. For more information,
visit www.lucirahealth.com.
Investor Contact Greg Chodaczek
Investorrelations@lucirahealth.com332-895-3230
Lucira Health (NASDAQ:LHDX)
Historical Stock Chart
From Aug 2024 to Sep 2024
Lucira Health (NASDAQ:LHDX)
Historical Stock Chart
From Sep 2023 to Sep 2024